AIDS In The USA

At the 2008 joint meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Disease Society of America (IDSA), Tim Horn speaks with Roy M. Gulick, MD, MPH, a professor of medicine at the Weill College of Medicine of Cornell University and the director of the Cornell Clinical Trials Unit in New York. In this first of a two-part interview, Dr. Gulick reviews some of the noteworthy HIV presentation at ICAAC/IDSA, including new data suggesting that antiretroviral therapy is most effective when started when the CD4 count cascade below 500.

Related Blogs

• H1N1 VACCINE AIDS RISK WARNS TOP INFECTIOUS DISEASE DOCTORS | CancerType
• Interscience Conference on Antimicrobial Agents and Chemotherapy: Peginterferon alfa-2a plus Ribavirin in Patients with HIV and HCV Co-infection | Canadian Medicine
• 45th Interscience Conference on Antimicrobial Agents: Posaconazole Effective Against Zygomycosis – Anesthesia Progress Blog

Related posts:

1. HEALING HIV NEWS STORY Part 2
2. I just got news my husband is HIV positive what do I do?
3. VEHICLES: Conversion Project Could Aid Asia.: An article from: Fuel Cell Technology News
4. How come the news never mentions the high rate of HIV/AIDS infection of black people but they tell you about?
5. Did you hear on the news last week, that AIDS/HIV is now gonna be considered as a black disease?